Literature DB >> 28110297

The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association.

Giuseppe Mancia1, Suzanne Oparil2, Paul K Whelton3, Martin McKee4, Anna Dominiczak5, Friedrich C Luft6, Khalid AlHabib7, Fernando Lanas8, Albertino Damasceno9, Dorairaj Prabhakaran10, Giuseppe La Torre11, Michael Weber12, Martin O'Donnell13, Sidney C Smith14, Jagat Narula15.   

Abstract

Ingestion of sodium is essential to health, but excess sodium intake is a risk factor for hypertension and cardiovascular disease. Defining an optimal range of sodium intake in populations has been challenging and controversial. Clinical trials evaluating the effect of sodium reduction on blood pressure have shown blood pressure lowering effects down to sodium intake of less than 1.5 g/day. Findings from these blood pressure trials form the basis for current guideline recommendations to reduce sodium intake to less than 2.3 g/day. However, these clinical trials employed interventions that are not feasible for population-wide implementation (i.e. feeding studies or intensive behavioural interventions), particularly in low and middle-income countries. Prospective cohort studies have identified the optimal range of sodium intake to reside in the moderate range (3-5 g/day), where the risk of cardiovascular disease and death is lowest. Therefore, there is consistent evidence from clinical trials and observational studies to support reducing sodium intake to less than 5 g/day in populations, but inconsistent evidence for further reductions below a moderate intake range (3-5 g/day). Unfortunately, there are no large randomized controlled trials comparing low sodium intake (< 3 g/day) to moderate sodium intake (3-5 g/day) in general populations to determine the net clinical effects of low sodium intake. Until such trials are completed, it is likely that controversy about optimal sodium intake range will continue. This working group calls for the completion of large definitive clinical trials to clarify the range of sodium intake for optimal cardiovascular health within the moderate to low intake range. We support interventions to reduce sodium intake in populations who consume high sodium intake (> 5 g/day), which should be embedded within an overall healthy dietary pattern. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Hypertension ; LMIC; Sodium

Mesh:

Substances:

Year:  2017        PMID: 28110297     DOI: 10.1093/eurheartj/ehw549

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

1.  Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health.

Authors:  Feng J He; Norm R C Campbell; Yuan Ma; Graham A MacGregor; Mary E Cogswell; Nancy R Cook
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

Review 2.  Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment?

Authors:  Daniel W Jones; Friedrich C Luft; Paul K Whelton; Michael H Alderman; John E Hall; Eric D Peterson; Robert M Califf; David A McCarron
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

3.  Prediction of 24-hour sodium excretion from spot urine samples in South African adults: a comparison of four equations.

Authors:  Karen Charlton; Lisa J Ware; Glory Chidumwa; Marike Cockeran; Aletta E Schutte; Nirmala Naidoo; Paul Kowal
Journal:  J Hum Hypertens       Date:  2019-05-10       Impact factor: 3.012

Review 4.  Salt and Blood Pressure: Cutting Through the Scientific Fog.

Authors:  Emrush Rexhaj; Franz H Messerli; David Cerny; Juergen Bohlender
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

Review 5.  Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy.

Authors:  Massimo Volpe; Allegra Battistoni; Giovanna Gallo; Speranza Rubattu; Giuliano Tocci
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-09-20

Review 6.  The Influence of Dietary Salt Beyond Blood Pressure.

Authors:  Austin T Robinson; David G Edwards; William B Farquhar
Journal:  Curr Hypertens Rep       Date:  2019-04-25       Impact factor: 5.369

Review 7.  Nutrition and Cardiovascular Disease-an Update.

Authors:  Kate J Bowen; Valerie K Sullivan; Penny M Kris-Etherton; Kristina S Petersen
Journal:  Curr Atheroscler Rep       Date:  2018-01-30       Impact factor: 5.113

8.  Moving the Needle on Hypertension: What Knowledge Is Needed?

Authors:  Alissa A Frame; William B Farquhar; Marie E Latulippe; Alicia A McDonough; Richard D Wainford; Brandi M Wynne
Journal:  Nutr Today       Date:  2019 Nov-Dec

9.  Paucity of high-quality studies reporting on salt and health outcomes from the science of salt: A regularly updated systematic review of salt and health outcomes (April 2017 to March 2018).

Authors:  Kristina S Petersen; Sarah Rae; Erik Venos; Daniela Malta; Kathy Trieu; Joseph Alvin Santos; Sudhir Raj Thout; Jacqui Webster; Norm R C Campbell; JoAnne Arcand
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-27       Impact factor: 3.738

10.  Reducing population salt intake-An update on latest evidence and global action.

Authors:  Feng J He; Mhairi Brown; Monique Tan; Graham A MacGregor
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-26       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.